Search research articles
Contact Us
Filters
Showing results (461-470 of 1,018) with videos related to
Page
of 102
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 2006
Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide
Valerie Croons, Wim Martinet, Arnold G Herman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 17, 2009
The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase
Valerie Croons, Wim Martinet, Arnold G Herman, et al.
Genes & Cancer
|
July 1, 2015
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
Yongshuai Jin, Baoping Cao, Meiying Zhang, et al.
Advances in Cancer Research
|
October 24, 1997
Alterations in DNA methylation: a fundamental aspect of neoplasia
S B Baylin, J G Herman, J R Graff, et al.
British Journal of Pharmacology
|
May 14, 1998
Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB
T Iuvone, F D'Acquisto, N Van Osselaer, et al.
British Journal of Pharmacology
|
August 19, 2007
Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress
W Martinet, V Croons, J-P Timmermans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus
Mingzhou Guo, Jingli Ren, Michael G House, et al.
Clinical Epigenetics
|
May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
Wenji Yan, Kongming Wu, James G Herman, et al.
Biochemical Pharmacology
|
April 15, 1986
Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid
M Rampart, J R Beetens, H Bult, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1995
Acetylcholine-induced vasorelaxation in portal hypertensive rats
P P Michielsen, G E Boeckxstaens, S U Sys, et al.
Page
of 102
Search research articles
Search
Showing results (461-470 of 1,018) with videos related to
Sort By:
Page
of 102
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 2006
Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide
Valerie Croons, Wim Martinet, Arnold G Herman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 17, 2009
The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase
Valerie Croons, Wim Martinet, Arnold G Herman, et al.
Genes & Cancer
|
July 1, 2015
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
Yongshuai Jin, Baoping Cao, Meiying Zhang, et al.
Advances in Cancer Research
|
October 24, 1997
Alterations in DNA methylation: a fundamental aspect of neoplasia
S B Baylin, J G Herman, J R Graff, et al.
British Journal of Pharmacology
|
May 14, 1998
Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB
T Iuvone, F D'Acquisto, N Van Osselaer, et al.
British Journal of Pharmacology
|
August 19, 2007
Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress
W Martinet, V Croons, J-P Timmermans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus
Mingzhou Guo, Jingli Ren, Michael G House, et al.
Clinical Epigenetics
|
May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer
Wenji Yan, Kongming Wu, James G Herman, et al.
Biochemical Pharmacology
|
April 15, 1986
Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid
M Rampart, J R Beetens, H Bult, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1995
Acetylcholine-induced vasorelaxation in portal hypertensive rats
P P Michielsen, G E Boeckxstaens, S U Sys, et al.
Page
of 102